Trials / Completed
CompletedNCT02939638
Diet, Insulin Sensitivity, and Postprandial Metabolism
A Randomized, Controlled Trial on Diet, Insulin Sensitivity, and Postprandial Metabolism
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 220 (actual)
- Sponsor
- Physicians Committee for Responsible Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomized, controlled trial aims to elucidate the mechanisms by which a plant-based dietary intervention causes weight loss. Using a low-fat, plant-based diet for 16 weeks, along with an untreated control for comparison, the study will measure changes in body weight, body composition, intramyocellular and/or intrahepatocellular lipid, and changes in association to body weight.
Detailed description
In a 16-week trial, overweight adults will be randomly assigned to two groups. Changes in body weight, body composition, intramyocellular and/or intrahepatocellular lipid, and changes in association to body weight will be measured among other outcomes. The Intervention Group will follow a low-fat, vegan diet and will receive weekly classes and support. The Control Group will be asked to follow a conventional control diet. This study conducts a pilot sub-study to test the hypothesis that changes in insulin sensitivity and beta-cell function observed in response to a diet intervention correlate with changes in intramyocellular and/or intrahepatocellular lipid. Another sub-study assesses the association between metabolic outcomes and gut microbiome. One additional sub-study is looking for associations between metabolic outcomes and endothelial function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Plant-based diet | Weekly instructions will be given to the participants in the intervention group about following vegan diet. |
| OTHER | Control Diet | Participants will be asked to continue their usual diets for the 16-week study period. |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-12-01
- Completion
- 2019-01-09
- First posted
- 2016-10-20
- Last updated
- 2023-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02939638. Inclusion in this directory is not an endorsement.